Cardiac Equipment Market 2014-2020
Cardiovascular diseases (CVD) are one of the foremost public health challenge across the globe. According to World Organization (WHO) estimate, about 17.5 million people died from cardiovascular diseases in 2012, accounting for 31% of all global deaths. Around one third of CVD deaths take place in the low and middle income countries. By the year 2030, more than 23 million people are likely to die annually from cardiovascular diseases. Get detailed information visit @: https://www.alliedmarketresearch.com/cardiac-equipment-market
Cardiovascular diseases (CVD) are one of the foremost public health challenge across the globe. According to World Organization (WHO) estimate, about 17.5 million people died from cardiovascular diseases in 2012, accounting for 31% of all global deaths. Around one third of CVD deaths take place in the low and middle income countries. By the year 2030, more than 23 million people are likely to die annually from cardiovascular diseases.
Get detailed information visit @: https://www.alliedmarketresearch.com/cardiac-equipment-market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REPORT OVERVIEW<br />
New product approval and launch are among the few strategies adopted by top industry<br />
players. In April 2015, HeartWare International procured the Canadian marketing approval<br />
for HeartWare Ventricular Assist System, a small circulatory support device. Similarly,<br />
Philips has recently launched VesselNavigator, a 3D Navigation System intended for<br />
minimally invasive treatments of vascular diseases. In March <strong>2014</strong>, St. Jude Medical<br />
announced the approval of three pacemakers, Allure Quadra CRT-P, Assurity and Endurity<br />
pacemakers. The companies profiled in this report include, Medtronic plc, Boston Scientific<br />
Corporation, St. Jude Medical, Inc., Thoratec Corporation, HeartWare Inc., SynCardia<br />
Systems, Inc., Vasomedical, Inc., Sorin Group, Biotronik, Inc. and Berlin Heart, Inc.<br />
Global <strong>Market</strong> – By Geography<br />
North America<br />
Europe<br />
Asia-Pacific<br />
LAMEA
Change language